NeuroPace Q3 2026 Results: Net Loss of $3.3M, Loss Narrows
NeuroPace reported a decrease in total assets from $105.6 million at the end of 2025 to $94.8 million as of September 30, 2026, primarily driven by a reduction in cash and short-term investments. The company maintains a significant accumulated deficit of $568.6 million and expects to lose its emerging growth company status on December 31, 2026.
- Key figure
- Net loss $3.3M